Nuwellis (NUWE) announced that the U.S. Patent and Trademark Office, or USPTO, has issued a notice of allowance for a new patent covering its novel dual lumen midline catheter technology designed for use in ultrafiltration therapies. This catheter incorporates design elements to optimize blood flow dynamics during therapy. The technology includes separate withdrawal and infusion lumens with pressure-balancing features that help maintain stable flow and reduce complications associated with fluid removal procedures.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute
- Nuwellis announces return of three former team members
- Nuwellis expands commercial footprint with new South Texas territory
- Nuwellis Board Directors Resign Amid Governance Dispute
- Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech